Kajian sukarelawan sihat di Anaheim, CA
19 kajian di lokasi dalam dan sekitar Anaheim menerima sukarelawan sihat — iaitu individu tanpa keadaan yang dikaji. Banyak kajian membayar peserta untuk masa dan perjalanan mereka; jumlah ditentukan oleh setiap kajian, jadi sila tanya pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- CenExel Anaheim (Anaheim Clinical Trials), Anaheim
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- CenExel Act- Anaheim Clinical Trials /ID# 285208, Anaheim
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- CenExel ACT (Formerly Anaheim Clinical Trials; LLC), Anaheim
A Study of LY4226695 in Healthy Participants
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- CenExel ACT, Anaheim
Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Anaheim Clinical Trials ( Site 0002), Anaheim
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- Advanced Research Center, Inc., Anaheim
A Study of V132 in Healthy Older Participants (V132-001)
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Anaheim Clinical Trials ( Site 0006), Anaheim
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
- Investigative Site, Anaheim
Shield Post-Approval Study Protocol
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Elite Primary Physicians, Inc., Anaheim
A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Anaheim Clinical Trials ( Site 0001), Anaheim
A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- CenExel ACT- Anaheim Clinical Trials /ID# 284382, Anaheim
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Anaheim Clinical Trials, LLC, Anaheim
A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of Healthy Adult Participants
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- CenExel ACT- Anaheim Clinical Trials /ID# 281821, Anaheim
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Anaheim Clinical Trials, LLC, Anaheim
A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Anaheim Clinical Trials, Anaheim
Data Gathering for A10900
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Ketchum Health, Anaheim
Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Cenexel Anaheim CA, Anaheim
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- CenExel ACT (Formerly Anaheim Clinical Trials; LLC), Anaheim
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Kinetic Clinical Research, Anaheim
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.